Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Opening Plenary Session showcases important breakthroughs across the spectrum of cancer research
An expert panel of cancer researchers, including Tomi Akinyemiju, PhD, showcased cutting-edge research in diverse fields of study that is opening up new frontiers in all areas of cancer research, from basic science and drug discovery to population science and health equity.
-
Better Together: Opening Ceremony focuses on the power of collaboration
The AACR and the cancer research community benefit from collaborations with many oncology stakeholders and more than 100 cancer organizations around the world. “We share our passion to change the face of cancer and our belief that we are made stronger by working together,” said AACR CEO Margaret Foti, PhD, MD (hc).
-
Schedule highlights from the Program Chair: Monday, April 17
Annual Meeting Program Committee Chair Robert H. Vonderheide, MD, DPhil, shares a few highlights from Monday’s schedule to help you plan your day.
-
Researchers engaged in ongoing battle to defeat mutant KRAS
Sotorasib and adagrasib, the first agents to directly target mutant KRAS cancers, became overnight sensations when they were approved in 2021 and 2022, respectively. Four researchers, including Dafna Bar-Sagi, PhD, described the decades of research that led to the approvals during the first plenary session at the Annual Meeting. They also described ongoing research efforts to treat KRAS-mutated cancers.
-
Margaret Foti Award recipient is a force for change in cancer immunology and immunotherapy
AACR Past President Elizabeth M. Jaffee, MD, FAACR, recipient of the AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, will discuss her personal journey in cancer research during her award lecture Monday afternoon.
-
Presidential Select Symposium will tackle complex issues surrounding pregnancy and cancer
Among other topics, the session’s speakers will discuss evolving concerns in the current medical and sociopolitical environment, particularly when patient survival is compromised when therapies are deferred or omitted to prevent fetal exposure, according to AACR President Lisa M. Coussens, PhD, FAACR.
-
Monday’s schedule includes the first evening forum sessions of this year’s meeting
The Annual Meeting program features five forum sessions Monday evening on a range of topics, from adolescent and young adult cancers, CAR cells, and data-sharing, to taking cancer care out of the hospital and into the home.